Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Active Surveillance of the Safety of Gadolinium-based Contrast Agent(s) in India

NCT06257277 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT06257277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06257277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Active Surveillance of the Safety of Gadolinium-based Contrast Agent(s) in India
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
July 8, 2024
Completion date
May 26, 2025
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast enhancement in magnetic resonance imaging